Maviret (glecaprevir/pibrentasvir granules)

pCPA File Number: 22762
Negotiation Status:
Concluded with an LOI
Indication(s):
Pediatric Chronic Hepatitis C
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: